A world of possibilities
Navigating life sciences and medtech to the extraordinary—driven by creativity, curiosity, and the courage to build a fulfilling journey.
-
AI-Driven Drug Discovery & Computational Biology
What’s emerging AI-designed molecules target identification using multi-omics in silico screening replacing wet lab steps Liquid biopsy and early-detection platforms AI-assisted biomarker discovery Why it’s promising Cuts cost and time dramatically Big pharma partnerships everywhere…
-
First-Gen CRISPR (Cas9): Why Differentiation Was Limited
Core mechanism Double-strand DNA breaks (DSBs) Reliance on endogenous DNA repair (NHEJ / HDR) Therapeutic limitations Unpredictable repair outcomes Elevated risk of large deletions and chromosomal rearrangements p53 activation and genotoxic stress Limited applicability to…
-
RNA-Based Therapeutics & Regulation
What’s emerging mRNA beyond vaccines siRNA, antisense, circular RNA RNA editing and RNA regulation Why it’s promising Modularity and rapid design cycles Expanding delivery solutions IP significance Delivery remains the dominant value driver Claims increasingly…
